clinicaltrialsarena3 小时
FDA approves Zydus’ Phase IIb trial of Usnoflast for ALS treatment
The FDA has granted approval for Zydus to proceed with the Phase II(b) trial of Usnoflast for amyotrophic lateral sclerosis (ALS) treatment.